In this first edition of WeissWatch ThoughtLeaders – a new podcast series that features conversations with influential people in organizations around the world – guest Michael Fleming of GlaxoSmithKline USA and host Neville Hobson discuss communication and engagement in the pharma industry including the objectives behind and experiences with “More Than Medicine,” the GSK US public blog launched in May 2009; the role of social media; and commentary on the FDA social media hearing in November 2009 and implications for healthcare communications.
- Download the Podcast (MP3, 8.1Mb, 17:38)
To automatically receive future episodes as they are published, subscribe to the RSS feed. You can also subscribe at iTunes (coming soon).
About Our Guest
As head of new and social media communications for GSK US Pharmaceuticals, Michael Fleming is spearheading exploration and adoption of social media strategies across both product marketing and corporate communications. He leads the team that recently launched the first US pharma blog, “More than Medicine” and the company’s foray into Twitter. Previously, Michael led US product communications at GSK.
Before joining GSK, he held positions in global marketing, public affairs, and operations at Searle and DuPont Pharmaceuticals. Earlier in his career, Michael was a senior aide to a US Senator and he continues to be active in politics and civic affairs.
Do you have a comment, question or suggestion about this episode of The WeissWatch Podcast? Feel free to let us know what’s on your mind – leave a comment in this post for inclusion in the next episode. If you wish, you can email your comment, question or suggestion as an MP3 file attachment (max 3 minutes / 5Mb file size) to firstname.lastname@example.org.
Podsafe music from Moving On Swiftly by The Smallvilles.
Enjoy the show!